Skip to main content

Find Clinical Trials

Home
Conditions
Neuralgia, Postherpetic

Clinical trial condition

Neuralgia, Postherpetic

Explore clinical trials studying Neuralgia, Postherpetic. Study availability and eligibility vary by location and protocol.

154 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Neuralgia, Postherpetic trial results

Completed

A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)

NCT00160511

Conditions: Nervous System Diseases, Neuralgia, Neuralgia, Postherpetic, +6 more
Locations: Not specified

View Trial Details

Completed

A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN)

NCT01195636

Conditions: Nervous System Diseases, Neuralgia, Neuralgia, Postherpetic, +7 more
Locations: Jonesboro, Arkansas, United States

Lomita, California, United States

Westlake Village, California, United States

Bradenton, Florida, United States

View all 24 locations

View Trial Details

Completed

A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia

NCT01129531

Conditions: Nervous System Diseases, Neuralgia, Neuralgia, Postherpetic, +6 more
Locations: Orlando, Florida, United States

Brno, Czechia

Kiel, Germany

Katowice, Poland

View Trial Details

Completed

A Comparative Study of KHK6188

NCT01544296

Conditions: Nervous System Diseases, Neuralgia, Neuralgia, Postherpetic, +7 more
Locations: Japan Arakawa-ku, Tokyo, Japan

View Trial Details

Completed

Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain

NCT00415597

Conditions: Arthralgia, Back Pain, Chronic Pain, +11 more
Locations: Michael Gibson, MD Birmingham, Alabama, United States

Steven Siwek, MD Phoenix, Arizona, United States

Michael Loes, MD Phoenix, Arizona, United States

Allan Soo, MD Tempe, Arizona, United States

View all 58 locations

View Trial Details

Completed

A Confirmatory Study of Fentanyl in Participants With Post-herpetic Neuralgia, Complex Regional Pain Syndrome or Postoperative Pain Syndrome

NCT01008553

Conditions: Autonomic Nervous System Diseases, Complex Regional Pain Syndromes, Complex Regional Pain Syndromes (CRPS), +14 more
Locations: Aichi, Japan

Amagasaki, Japan

Asahikawa, Japan

Bunkyō City, Japan

View all 79 locations

View Trial Details

Completed

A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)

NCT00619476

Conditions: Nervous System Diseases, Neuralgia, Neuralgia, Postherpetic, +6 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Northport, Alabama, United States

GSK Investigational Site Chandler, Arizona, United States

GSK Investigational Site Gilbert, Arizona, United States

View all 83 locations

View Trial Details

Completed

A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment

NCT00617461

Conditions: Nervous System Diseases, Neuralgia, Neuralgia, Postherpetic, +6 more
Locations: GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Oxnard, California, United States

GSK Investigational Site Roseville, California, United States

GSK Investigational Site San Francisco, California, United States

View all 53 locations

View Trial Details

Completed

Shingles Prevention Study

NCT00007501

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +13 more
Locations: VA Medical Center, Birmingham Birmingham, Alabama, United States

VA Palo Alto Health Care System Palo Alto, California, United States

VA San Diego Healthcare System, San Diego San Diego, California, United States

University of Colorado Denver, Colorado, United States

View all 22 locations

View Trial Details

Completed

Phase IV Study of FDA Approved, Once-Daily GRALISE™(Gabapentin) Tablets for the Treatment of Postherpetic Neuralgia

NCT01426230

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +13 more
Locations: Mobile, Alabama, United States

Tuscaloosa, Alabama, United States

Phoenix, Arizona, United States

Sun City, Arizona, United States

View all 37 locations

View Trial Details